Search Results

• • 9 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Fulvestrant: A Review in Advanced Breast Cancer Not Previously Treated with Endocrine Therapy

  Author:Emma D. DeeksFrom:Drugs (Vol. 78, Issue 1) Peer-Reviewed

  Jan. 1, 2018 Article

   Citation Only

• Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages

  Authors:Gabor Hollo, Andreas Katsanos, Kostas G. Boboridis, and Murat IrkecFrom:Drugs (Vol. 78, Issue 1) Peer-Reviewed

  Jan. 1, 2018 Article

   Citation Only

• Dimethyl Fumarate: A Review in Moderate to Severe Plaque Psoriasis

  Author:Hannah A. BlairFrom:Drugs (Vol. 78, Issue 1) Peer-Reviewed

  Jan. 1, 2018 Article

   Citation Only

• Letermovir: First Global Approval

  Author:Esther S. KimFrom:Drugs (Vol. 78, Issue 1) Peer-Reviewed

  Jan. 1, 2018 Article

   Citation Only

• Correlation of Opioid Mortality with Prescriptions and Social Determinants: A Cross-sectional Study of Medicare Enrollees

  Authors:Christos A. Grigoras, Styliani Karanika, Elpida Velmahos, and Michail AlevizakosFrom:Drugs (Vol. 78, Issue 1) Peer-Reviewed

  Jan. 1, 2018 Article

   Citation Only

• Acalabrutinib: First Global Approval

  Authors:Sohita Dhillon and Anthony MarkhamFrom:Drugs (Vol. 78, Issue 1) Peer-Reviewed

  Jan. 1, 2018 Article

   Citation Only

• Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

  Authors:Arrigo F. G. Cicero, Matteo Pirro, Gerald F. Watts, and Dimitri P. MikhailidisFrom:Drugs (Vol. 78, Issue 1) Peer-Reviewed

  Jan. 1, 2018 Article

   Citation Only

• Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update

  Authors:Inger S. Nijhof, Niels W. C. J. van de Donk, Sonja Zweegman, and Henk M. LokhorstFrom:Drugs (Vol. 78, Issue 1) Peer-Reviewed

  Jan. 1, 2018 Article

   Citation Only

• Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-beta-Lactamase Inhibitor Combinations

  Authors:George G. Zhanel, Courtney K. Lawrence, Heather Adam, and Frank SchweizerFrom:Drugs (Vol. 78, Issue 1) Peer-Reviewed

  Jan. 1, 2018 Article

   Citation Only